Computational and Experimental Evaluation of Plant - Derived Bioactive Compounds in Oncology Research
AMH Biotech is expanding its research platform into oncology through the investigation of highly purified plant-derived bioactive compounds using integrated computational and experimental methodologies. AMH Biotech’s immediate oncology research objective is to investigate whether selected highly purified plant-derived compounds may have potential future applications in adjunctive oncology research settings.”
- Our oncology research program combines:
Molecular docking - Molecular dynamics simulations
- Surface Plasmon Resonance (SPR)
- ELISA-based assays
- Cancer cell studies
- Early-stage animal model evaluation
The objective of this research program is to identify naturally derived compounds with favorable interaction profiles against cancer-associated molecular pathways and targets.
Lead Compound Discovery
AMH Biotech has identified three investigational lead compounds through multi-stage computational screening and experimental validation workflows.
Lead compounds were selected based on:
- Binding affinity characteristics
- Molecular stability during dynamics simulations
- Experimental target interaction data
- Preliminary biological activity profiles
One investigational lead compound is currently undergoing further evaluation in breast cancer-related research models.
Collaborative Research Activities
AMH Biotech is collaborating with academic and scientific researchers associated with:
- Temple University
- Rowan University
Current collaborative activities include:
- Cancer cell viability studies
- Mechanism-focused laboratory assays
- Molecular target evaluation
- Early-stage animal studies
Initial preclinical evaluations are currently underway.
Scientific Rationale
Naturally occurring flavonoids and related polyphenolic compounds continue to attract scientific interest because of their reported interactions with pathways associated with:
- Cellular signaling
- Oxidative stress regulation
- Cell proliferation
- Apoptosis-related mechanisms
- Estrogen-related signaling pathways
AMH Biotech is focused on evaluating these interactions using computational biology and laboratory validation systems designed to support early-stage oncology research.
Research Platform
Our integrated workflow includes:
Computational Biology
- Molecular docking
- Multi-target screening
- Molecular dynamics simulations
- Binding interaction analysis
Experimental Validation
- Surface Plasmon Resonance (SPR)
- ELISA assays
- Cancer cell assays
- Biomarker-focused studies
Preclinical Evaluation
- Cell viability studies
- Animal model assessment
- Safety and tolerability observations
Research Disclosure
The investigational compounds and research activities described on this website are in preclinical research stages only and are not approved for the diagnosis, treatment, cure, mitigation, or prevention of cancer or any other disease.
All oncology-related therapies and medical decisions should be discussed with qualified licensed healthcare professionals.
AMH - BIOTECH
